VIA
VBIV

Vident Investment Advisory’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Vident Investment Advisory’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-561
Closed -$16K – 896
2020
Q1 		$16K Buy
+561
New +$21.8K ﹤0.01% 784

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vident Investment Advisory's VBIV Position: Q2 2020 in Review

Vident Investment Advisory sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2020, closing a stake of 561 shares — an estimated $16K sold.

Vident Investment Advisory first reported a position in VBIV in Q1 2020 and held it in 1 quarter. The position peaked at $16K in Q1 2020. 102 funds tracked by Wall St. Rank hold VBIV as of Q2 2020.

  • Vident Investment Advisory reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2020 after selling out during the quarter.
  • Vident Investment Advisory sold 561 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2020, an estimated $16K.
  • Vident Investment Advisory first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2020 and held it in 1 quarter.
  • Vident Investment Advisory's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $16K in Q1 2020.
  • 102 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2020.

Based on Vident Investment Advisory's 13F filing for Q2 2020, filed 17 Jul 2020.